10 | $AROW News Article - Expected earnings - Arrow | whytestocks | 10/25/2023 11:20:47 AM |
9 | $AROW News Article - TUESDAY DEADLINE NOTICE: The | whytestocks | 08/18/2023 11:45:46 AM |
8 | $AROW News Article - 3-DAY DEADLINE ALERT: The | whytestocks | 08/18/2023 10:15:47 AM |
7 | $AROW News Article - Arrow Reports $12.2 million | whytestocks | 10/27/2022 3:25:53 PM |
6 | AROW 27.07 Arrow Financial Corp Stock Charts | chartguy89 | 02/26/2015 11:31:54 PM |
5 | AROW Stock year to date has changed -1.53% | Jake13 | 02/26/2015 11:29:28 PM |
4 | Latest Arrow Financial Corp (AROW) Headlines SY | Stock_Tracker | 03/12/2014 6:03:06 PM |
3 | AROW Recent News SY Bancorp Upped to Strong Buy - | Stock_Tracker | 03/02/2014 2:05:07 AM |
2 | AROW Stock Charts Last: +0.05 Wednesday, February | chartguy89 | 02/26/2014 9:35:13 PM |
1 | Arrow Financial (NASDAQ: AROW) Chairman Buys | EmergingGrowth | 02/13/2013 11:43:39 AM |
Recent Articles
- Opportunity for Wolfspeed Investors to Pursue Class Action
- Kyverna Therapeutics Investors Alert Over Recent Class Action
- Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
- Urgent Alert for Symbotic Investors Regarding Class Action
- Investors Reminded of Key Deadline in PACS Group Lawsuits
- Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
- Important Update for Rentokil Investors on Class Action Lawsuit
- Important Update for Match Group Investors: Legal Actions Ahead
- Investors Urged to Act in Zeta Global Class Action Case
- Celsius Holdings Investors: Important Litigation Updates
- ASML Holding Class Action: Important Update for Investors
- Deadline Approaches for Hasbro Shareholders in Class Action
- Critical Update for Toronto-Dominion Bank Investors in Class Action
- Investors of Kyverna Therapeutics Can Pursue Class Action
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement
- Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
- OFS Credit Company Shares November Net Asset Value Insights
- New FDA Approval for Crenessity Enhances CAH Treatment Options